ENTA
Enanta Pharmaceuticals Inc
11.90$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 120.6% | 162.9% | 200.2% | 267.4% | 27.7% | 60.7% | 60.3% | 59.3% | 47.8% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.7% | 3.2% | 2.2% | 3.0% | 3.4% | 3.5% | 3.6% | 3.6% | 3.3% | 3.3% | 5.2% | 8.1% | – | 8.5% | – | 7.0% | 8.4% | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.3% | 96.8% | 97.8% | 97.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.0% | 100.0% | 98.1% | |
| 89.6% | 120.2% | 145.2% | 205.1% | 21.7% | 47.1% | 48.8% | 49.7% | 40.1% | 49.9% | 86.2% | 77.7% | 75.5% | 62.4% | 118.1% | 185.9% | 155.2% | 115.5% | 206.2% | 217.3% | 207.6% | 175.6% | 224.9% | 200.7% | 171.3% | 173.4% | 244.3% | 227.5% | 191.0% | 202.0% | 208.7% | 159.9% | 210.7% | 163.1% | 188.0% | 148.6% | 157.4% | 112.1% | 113.3% | 154.1% | 132.1% | |
| 34.6% | 47.4% | 61.0% | 69.7% | 6.7% | 15.1% | 13.0% | 10.7% | 8.7% | 10.2% | 17.1% | 13.9% | 12.0% | 13.2% | 24.9% | 36.6% | 28.5% | 23.2% | 41.4% | 39.2% | 35.4% | 34.4% | 56.0% | 66.4% | 61.9% | 53.8% | 77.4% | 66.8% | 72.9% | 91.8% | 83.5% | 74.6% | 93.7% | 75.7% | 76.3% | 54.6% | 64.1% | 48.4% | 55.8% | 65.9% | 57.8% | |
| 124.1% | 167.6% | 206.1% | 274.8% | 28.5% | 62.3% | 61.7% | 60.5% | 48.7% | 60.1% | 103.3% | 91.5% | 87.5% | 75.5% | 143.0% | 222.5% | 183.7% | 138.7% | 247.5% | 256.5% | 243.1% | 210.0% | 280.8% | 263.4% | 229.9% | 225.1% | 318.7% | 294.3% | 263.9% | 293.8% | 292.1% | 234.6% | 304.4% | 238.8% | 264.3% | 203.2% | 221.6% | 160.5% | 162.0% | 220.0% | 188.1% | |
| -24.1% | -67.6% | -106.1% | -174.8% | 71.5% | 37.7% | 38.3% | 39.5% | 51.3% | 39.9% | -3.3% | 8.5% | 12.5% | 24.5% | -43.0% | -122.5% | -83.7% | -38.7% | -147.5% | -156.5% | -143.1% | -110.0% | -180.8% | -167.1% | -133.1% | -127.3% | -221.7% | -194.3% | -163.9% | -193.8% | -192.1% | -134.6% | -204.4% | -138.8% | -164.3% | -103.2% | -121.6% | -60.5% | -69.1% | -120.0% | -90.0% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 2.4% | 2.3% | 7.2% | 2.7% | – | – | 17.2% | 3.9% | 7.1% | – | 17.0% | – | 2.7% | – | 2.3% | – | 1.4% | 2.0% | 3.5% | 6.4% | 13.4% | 10.6% | 16.6% | 19.1% | 15.0% | 13.1% | 17.7% | 11.6% | 11.5% | 8.8% | 15.8% | 16.6% | 19.3% | 28.8% | 19.8% | |
| -20.5% | -62.6% | -100.0% | -166.8% | 72.4% | 40.2% | 40.7% | 41.9% | 53.4% | 42.6% | 2.4% | 13.9% | 17.0% | 28.4% | -35.9% | -114.8% | -78.9% | -36.6% | -144.8% | -154.5% | -141.7% | -109.1% | -179.5% | -165.0% | -129.6% | -123.0% | -211.4% | -184.4% | -155.9% | -189.0% | -184.8% | -128.3% | -199.8% | -133.9% | -160.5% | -99.5% | -123.4% | -64.0% | -76.3% | -135.6% | -96.7% | |
| -6.4% | -14.8% | -39.8% | -54.6% | 24.3% | 9.6% | 12.2% | 6.4% | 12.6% | 5.3% | -8.1% | -2.0% | -0.9% | 2.9% | -14.2% | -38.3% | 45.3% | -10.4% | -35.3% | -43.4% | -37.3% | -0.1% | -1.4% | -2.3% | 0.1% | -0.1% | 0.2% | 22.3% | -7.4% | -3.5% | -2.1% | -2.2% | -2.5% | -2.5% | -8.7% | 0.2% | 0.2% | 0.1% | 0.0% | 0.3% | 0.2% | |
| -14.0% | -47.8% | -60.2% | -112.2% | 48.1% | 30.7% | 28.5% | 35.4% | 40.8% | 37.2% | 10.5% | 15.9% | 17.9% | 25.6% | -21.7% | -76.5% | -124.2% | -26.2% | -109.5% | -111.1% | -104.3% | -108.9% | -179.5% | -162.7% | -129.7% | -122.9% | -211.6% | -206.8% | -148.5% | -185.6% | -182.7% | -126.1% | -197.3% | -131.4% | -151.7% | -99.7% | -123.6% | -64.1% | -76.3% | -135.8% | -96.9% | |
| -16.8% | -57.8% | -100.2% | -167.4% | 72.3% | 39.3% | 39.7% | 40.7% | 52.2% | 40.8% | -1.3% | 10.5% | 14.3% | 26.2% | -39.7% | -117.6% | -79.9% | -36.0% | -143.4% | -150.7% | -138.2% | -106.2% | -175.1% | -161.4% | -126.4% | -120.9% | -208.3% | -170.4% | -135.7% | -166.3% | -166.2% | -111.9% | -178.9% | -117.1% | -140.9% | -84.1% | -99.2% | -40.8% | -49.9% | -106.8% | -71.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.